Additional work of the same group showed that CCR2-64I polymorphism might contribute to the establishment of high-grade squamous intraepithelial lesions through the disruption of the naturally fragile immune response that is directed towards human papillomavirus infection [37]. This evidence concerns the gene CCR2 and squamous cell intraepithelial neoplasia.